M&A News: Johnson & Johnson Has $3.4B Eye Biotech Ollin Biosciences in Its Sights
Shares in U.S. medical giant Johnson & Johnson ($JNJ) were higher in pre-market trading today on reports that it has set its sights on buying eye d...
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 3,142,900 | $352,287,661 | -18% | 0.04% | |
| 2. | 2,650,000 | $297,038,490 | 0.44% | ||
| 3. | 2,587,300 | $290,010,457 | +101% | 0.1% | |
| 4. | 2,306,600 | $258,546,794 | +11% | 0.03% | |
| 5. | Citadel Investment Group Ken Griffin | 1,833,406 | $205,506,478 | +42% | 0.02% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $119.92 | 84 | $10,114.19 | 9,115 | 2026-11-09 | Filing | |
| $121.38 | 243 | $29,435.71 | 42,558 | 2026-11-09 | Filing | |
| $119.92 | 127 | $15,171.29 | 42,315 | 2026-11-09 | Filing | |
| $137.32 | 84 | $11,540.96 | 9,031 | 2026-08-10 | Filing | |
| $137.10 | 245 | $33,592.28 | 42,189 | 2026-08-10 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $124.13 | 57,754 | $7,169,004.02 | 771,599 | 2026-09-18 | Filing | |
| $123.35 | 42,246 | $5,211,044.10 | 829,353 | 2026-09-18 | Filing | |
| $147.36 | 25,198 | $3,713,177.28 | 516,017 | 2026-08-11 | Filing | |
| $146.80 | 19,802 | $2,906,933.60 | 541,215 | 2026-08-11 | Filing | |
| $145.23 | 9,500 | $1,379,685.00 | 64,448 | 2026-08-11 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 52,300,520 | $5,862,365,242 | 0.09% | |
| 2. | 49,119,835 | $5,505,842,305 | 0.12% | |
| 3. | 34,979,056 | $3,920,802,766 | 0.2% | |
| 4. | 33,544,999 | $3,760,058,938 | 0.11% | |
| 5. | 25,582,966 | $2,867,594,659 | 0.37% |